Implantable Cardiac Signal Filtering for T-Wave Oversensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable medical devices (IMDs) face challenges in accurately filtering cardiac electrical signals, leading to T-wave oversensing and arrhythmia undersensing due to inappropriate signal filtering, which can result in inappropriate therapy delivery for ventricular fibrillation and tachycardia.
Innovation Solution
Implementing a system with two bandpass filters of different frequency ranges and a controller to dynamically switch between them based on specific criteria, ensuring accurate R-wave detection by adjusting the filtering mode to minimize both T-wave oversensing and R-wave undersensing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a narrow bandpass filter (6-25 Hz or 8-25 Hz) is used to reduce T-wave oversensing, then T-wave detection accuracy improves, but R-wave detection reliability deteriorates
Solution Approach 1:
The system dynamically switches between narrow and wide bandpass filters based on real-time signal characteristics and detected arrhythmia episodes. The controller adjusts the filtering mode from static to dynamic, selecting the appropriate filter bandwidth according to the current cardiac rhythm state to optimize both T-wave and R-wave detection accuracy.
Solution Approach 2:
The system changes the frequency parameter of the bandpass filter dynamically. During sinus rhythm, a narrow bandpass filter (6-25 Hz or 8-25 Hz) is used to reduce T-wave oversensing. During detected arrhythmia episodes, the system switches to a wide bandpass filter (3-25 Hz) to ensure reliable R-wave detection, thus adapting the filter parameter to the current physiological state.
2Reliability
If a wide bandpass filter (3-25 Hz) is used to ensure R-wave detection, then R-wave sensing reliability improves, but T-wave oversensing increases
Solution Approach 1:
The system employs dynamic filter selection where the controller switches between wide and narrow bandpass filters based on the detected cardiac rhythm. During arrhythmia episodes, the wide bandpass filter (3-25 Hz) is activated to ensure reliable R-wave detection. During sinus rhythm, the system transitions to a narrow bandpass filter to minimize T-wave oversensing, thus dynamically adapting to reduce harmful effects.
Solution Approach 2:
The frequency parameters of the bandpass filter are changed based on the detected rhythm state. The controller switches from a wide bandpass filter (3-25 Hz) that allows more frequencies including T-waves during arrhythmia detection, to a narrow bandpass filter (6-25 Hz or 8-25 Hz) that excludes T-wave frequencies during sinus rhythm, thereby controlling the harmful T-wave oversensing effect.
3Object-affected harmful factors
If fixed filtering is applied to remove noise, then signal noise reduction improves, but arrhythmia detection accuracy deteriorates
Solution Approach 1:
The system transitions from fixed filtering to dynamic adaptive filtering. The controller monitors for arrhythmia episodes and automatically switches between narrow and wide bandpass filters based on the detected rhythm state. This dynamic adaptation allows the system to maintain noise reduction during sinus rhythm while ensuring accurate arrhythmia detection when needed, resolving the contradiction between noise filtering and detection accuracy.
Solution Approach 2:
The filtering parameters are changed dynamically based on the detected cardiac state. During sinus rhythm, a narrow bandpass filter (6-25 Hz or 8-25 Hz) is used to filter out T-wave frequencies and reduce noise. When an arrhythmia episode is detected, the system switches to a wide bandpass filter (3-25 Hz) to capture all relevant frequency components for accurate arrhythmia detection, thus adapting the filter parameters to the current physiological state.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively reduces the likelihood of false detections of ventricular fibrillation and tachycardia by dynamically switching between filtering modes, thereby enhancing the accuracy of R-wave sensing and ensuring appropriate therapy delivery.
Implementation Method 1
The first bandpass filter is configured to pass frequencies within a first frequency range and can be used to produce a first filtered version of the signal indicative of cardiac electrical activity. The second bandpass filter is configured to pass frequencies within a second frequency range and can be used to produce a second filtered version of the signal indicative of cardiac electrical activity
Data Source
AI summary
Described herein are implantable medical devices and systems, and methods for use therewith, for reducing T-wave oversensing and arrythmia undersensing that occur due to inappropriate filtering of a signal indicative of cardiac electrical activity. A method includes obtaining a signal indicative of cardiac electrical activity, and using a first bandpass filter to produce a first filtered version thereof, using a second bandpass filter to produce a second filtered version thereof, wherein the first bandpass filter passes frequencies within a first frequency range, and the second bandpass filter passes frequencies within a second frequency range that is wider than the first frequency range. The method also includes selectively changing from using the first filtered version of the signal to monitor for a VS event, to using the second filtered version of the signal to monitor for a VS event, based on first criteria, and vice versa, based on second criteria.